div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: 2 12 41-44webdeuedutrtepdpdf2_122_12_41-44pdfTiroid kanserlerinin yakla k % 90nt olu turan iyi ditteransiye tiroid kanserinde 1-131 hem tan hem de sa altlm amaclyla kullarulabilir src=https:reader034vdocumentscoreader034viewer2022052615608893c347c5386c442e200fhtml5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: 2 12 41-44webdeuedutrtepdpdf2_122_12_41-44pdfTiroid kanserlerinin yakla k % 90nt olu turan iyi ditteransiye tiroid kanserinde 1-131 hem tan hem de sa altlm amaclyla kullarulabilir src=https:reader034vdocumentscoreader034viewer2022052615608893c347c5386c442e200fhtml5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: 2 12 41-44webdeuedutrtepdpdf2_122_12_41-44pdfTiroid kanserlerinin yakla k % 90nt olu turan iyi ditteransiye tiroid kanserinde 1-131 hem tan hem de sa altlm amaclyla kullarulabilir src=https:reader034vdocumentscoreader034viewer2022052615608893c347c5386c442e200fhtml5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: 2 12 41-44webdeuedutrtepdpdf2_122_12_41-44pdfTiroid kanserlerinin yakla k % 90nt olu turan iyi ditteransiye tiroid kanserinde 1-131 hem tan hem de sa altlm amaclyla kullarulabilir src=https:reader034vdocumentscoreader034viewer2022052615608893c347c5386c442e200fhtml5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdiv